Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours "REVASCAT"

Terminated

Phase 3 Results N/A

References

Publications

  • Molina CA, Chamorro A, Rovira A, de Miquel A, Serena J, Roman LS, Jovin TG, Davalos A, Cobo E. REVASCAT: a randomized trial of revascularization with SOLITAIRE FR® device vs. best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight-hours of symptom onset. Int J Stroke. 2013 Nov 10. doi: 10.1111/ijs.12157. [Epub ahead of print] Pubmed ID:24206399

Related Links

Sources for Trial Information